鱼类水产养殖实验性生物膜疫苗综述
本文综述鱼类生物膜疫苗对抗细菌性疾病的研究进展,涵盖气单胞菌、弧菌、发光杆菌和链球菌等病原体的浮游态与生物膜来源疫苗。这些疫苗通过诱导吞噬作用、先天免疫相关基因表达和特异性抗体展现安全性免疫原性,攻击试验中保护率可达77%至100%,而浮游态来源疫苗约30%。口服免疫是最常研究和理想的接种途径。
要点
- 生物膜疫苗在多种鱼类中攻毒保护率达77%至100%,浮游态疫苗约30%。
- 疫苗通过吞噬作用、先天免疫基因表达和特异性抗体诱导安全免疫原性。
- 口服免疫是最常研究和理想的接种途径,其他途径也有探索。
核心结论
- 生物膜来源疫苗在鱼类中展现77%至100%的攻毒保护率,优于浮游态来源疫苗约30%的保护率。
研究设计与样本
- 综述涵盖气单胞菌属、弧菌属、发光杆菌属和链球菌属等病原体的浮游态与生物膜来源疫苗研究。
主要发现
- 生物膜疫苗通过诱导吞噬作用、先天免疫相关基因表达和特异性抗体展现安全免疫原性。
- 多种鱼类攻毒试验中生物膜疫苗保护率范围为77%至100%。
- 浮游态来源疫苗保护率约30%。
- 口服免疫是最常研究和理想的接种途径,其他途径也有探索。
关键数值与推荐
- 生物膜疫苗保护率77%至100%,浮游态疫苗约30%,对象为多种鱼类攻毒试验。
临床怎么用
- 口服免疫是鱼类生物膜疫苗最常研究和理想的接种途径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Biofilm vaccines in fish are a trending approach to fighting bacterial diseases. Pathogens, including Aeromonas spp., Vibrio spp., Photobacterium spp., and Streptococcus spp., have been studied for planktonic- and biofilm-derived vaccines. These vaccines have demonstrated safe immunogenicity through the induction of phagocytosis, innate-immune related gene expression, and specific antibodies. Remarkably, protective outcomes range from 77 to 100% in several fish species upon challenges by disrupting biofilm formation, compared to planktonic-derived vaccines that have reached around 30% protection. Oral immunization is the most investigated and desirable route, although other routes have been explored. A comprehensive review of the state-of-the-art biofilm-based vaccines is described, including mechanisms of biofilm formation, biofilm-derived antigens, and strategies for their evaluation, providing experimental results along with benefits, obstacles, and perspectives for their affordable use in fish aquaculture.
引用
- Loera-Muro A, Ramos-Vega A, León-Montoya H, et al. Experimental biofilm vaccines for fish aquaculture: an overview. Vaccine. 2026. PMID: 42762721. doi:10.1016/j.vaccine.2026.129152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。